Allergan says 'Botax' wouldn't hurt sales much

Botox maker Allergan says a proposed tax on cosmetic surgeries and procedures--such as Botox injection--would have a small impact on the company, but it's still actively fighting the measure. Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.